In lung cancer cell lines NSCLC H460 and A549, elemene enhances cisplatin activity by increasing checkpoint kinase (CHK2) and reducing CDC2 (Li et al., 2013d). The gene discussed is CHEK2; the disease is non-small cell lung carcinoma.